Biologics Market

Biologics Market Trends, Share, Growth Drivers, Business Analysis and Future Investment 2030: Markntel Advisors

Global Biologics Market Insights Report Overview

The Global Biologics Market size is valued at USD 408.5 billion in 2024 and is projected to grow at a CAGR of around 8.25% during the forecast period, i.e., 2024-30.

Our report offers a thorough examination of the global landscape, providing valuable data, impartial analysis, and strategic insights to drive informed decision-making.

Report’s Study Period:

  • Historical Period: 2019-22
  • Base Year: 2023
  • Forecasting Period: 2024-30

We accurately gather data from primary and secondary sources, capturing the industry’s historical fluctuations and trends, including market dynamics, consumer behavior, manufacturing insights, and more. Leveraging this data alongside the base year information, we project the industry’s trajectory into the future.

Request Free Sample Report: https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

Industry Driving Factor:

Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth –

Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.

Segmentation Summary: Global Biologics Market

Our report delves into the intricate segmentation of the Biologics Market, providing insights into each subdivision’s trajectory, trends, and advancements. This analysis empowers stakeholders to navigate the industry landscape with precision, understanding the nuances of each segment.

By Therapeutic Application

-Oncology- Market Size & Forecast 2019-2030, (USD Million)

-Infectious Disease- Market Size & Forecast 2019-2030, (USD Million)

-Autoimmune Disease- Market Size & Forecast 2019-2030, (USD Million)

-Diabetes- Market Size & Forecast 2019-2030, (USD Million)

-Cardiovascular Diseases- Market Size & Forecast 2019-2030, (USD Million)

-Others

By Drug Class

-Recombinant Proteins- Market Size & Forecast 2019-2030, (USD Million)

-Hormones- Market Size & Forecast 2019-2030, (USD Million)

-Cytokines- Market Size & Forecast 2019-2030, (USD Million)

-Monoclonal Antibodies- Market Size & Forecast 2019-2030, (USD Million)

-Blood & Blood Components- Market Size & Forecast 2019-2030, (USD Million)

-Cellular & Gene Therapy- Market Size & Forecast 2019-2030, (USD Million)

-Vaccines- Market Size & Forecast 2019-2030, (USD Million)

-Others- Market Size & Forecast 2019-2030, (USD Million)

By Source

-Microbes- Market Size & Forecast 2019-2030, (USD Million)

-Humans- Market Size & Forecast 2019-2030, (USD Million)

-Others

Read Full Report: https://www.marknteladvisors.com/research-library/global-biologics-market.html

Leading Competitive:  Global Biologics Market

  • Bristol-Myers Squibb
  • Pfizer
  • Sanofi
  • Janssen Biotech Inc.
  • Bayer AG
  • Merck & Co.
  • Amgen Inc.
  • Abbott GmbH
  • Novartis
  • AstraZeneca Plc
  • GlaxoSmithKline Biologicals
  • Moderna Inc.
  • Others

Geographical Reach:

The Biologics Market  spans across various regions, each characterized by unique cultural, regulatory, and economic factors. Our regional analysis provides a comprehensive overview and forecast, considering these differences and assessing market players’ presence, consumer preferences, and more.

 By Region

-North America

-South America

-Europe

-The Middle East & Africa

-Asia-Pacific

Request Customization – https://www.marknteladvisors.com/query/request-customization/global-biologics-market.html

 Key Focus Areas:

  • What are the primary drivers and trends influencing the Biologics market growth, and how is the market structured?
  • How are segments within the Biologics market defined, and what is the size of each segment?
  • Which segments and geographical regions present the most promising growth opportunities?
  • What does the competitive landscape look like, and how do key players position themselves within the market?

About Us

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.

Contact Us –

Call: 📞 +1 628 895 8081 +91 120 4278433

Email: 📧 sales@marknteladvisors.com

Visit to know more: 🌐 https://www.marknteladvisors.com/

 

WhatsApp WhatsApp Us 24/7